Please use this identifier to cite or link to this item:
https://scholarhub.balamand.edu.lb/handle/uob/6680
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Saleh, Mustafa | en_US |
dc.contributor.author | Dib, AlFadel | en_US |
dc.contributor.author | Beaini, Sarah | en_US |
dc.contributor.author | Saad, Charbel | en_US |
dc.contributor.author | Faraj, Sary | en_US |
dc.contributor.author | El Joueid, Youssef | en_US |
dc.contributor.author | Kotob, Yasmine | en_US |
dc.contributor.author | Saoudi, Lara | en_US |
dc.contributor.author | Emmanuel, Nancy | en_US |
dc.date.accessioned | 2023-03-06T12:43:08Z | - |
dc.date.available | 2023-03-06T12:43:08Z | - |
dc.date.issued | 2023-02-24 | - |
dc.identifier.uri | https://scholarhub.balamand.edu.lb/handle/uob/6680 | - |
dc.description.abstract | Neurofibromatosis type 1 (NF1) is a genetic disorder caused by a mutation in the NF1 gene. This disease presents with various system-based manifestations, including cardiac, musculoskeletal, and neuronal issues, which have been well-studied in previous research and have prompted the development of current and emerging treatments. These treatments, mainly medications targeting specific manifestations of NF1, aim to mitigate the negative impacts of the disease on patients' lives. NF1 is associated with an increased risk of malignancy and a significant decrease in life expectancy. In this paper, we review the current and emerging treatments for NF1 in relation to its system-based manifestations. | en_US |
dc.language.iso | eng | en_US |
dc.publisher | Springer | en_US |
dc.subject | Clinical trials | en_US |
dc.subject | Emerging treatments | en_US |
dc.subject | Management | en_US |
dc.subject | Neurofibromatosis 1 | en_US |
dc.subject | Neurofibromatosis type 1 | en_US |
dc.title | Neurofibromatosis type 1 system-based manifestations and treatments: a review | en_US |
dc.type | Journal Article | en_US |
dc.identifier.doi | 10.1007/s10072-023-06680-5 | - |
dc.identifier.pmid | 36826455 | - |
dc.contributor.affiliation | Faculty of Medicine | en_US |
dc.date.catalogued | 2023-03-06 | - |
dc.description.status | In Press | en_US |
dc.identifier.openURL | https://link.springer.com/article/10.1007/s10072-023-06680-5 | en_US |
dc.relation.ispartoftext | Neurological Sciences | en_US |
Appears in Collections: | Faculty of Medicine |
SCOPUSTM
Citations
7
checked on Sep 7, 2024
Record view(s)
65
checked on Sep 8, 2024
Google ScholarTM
Check
Altmetric
Altmetric
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.